Quanterix Corporation Receives FDA Breakthrough Device Designation for Blood Test for Alzheimer’s Disease Detection

The post Quanterix Corporation Receives FDA Breakthrough Device Designation for Blood Test for Alzheimer’s Disease Detection appeared first on News Directory 3.
©Reuters. BILLERICA, Mass. – Quanterix Corporation (NASDAQ: QTRX), a company specializing in ultrasensitive laboratory products and high-resolution diagnostics, recently received breakthrough device designation from the U.S. Food and Drug Administration (FDA) for its blood test for the diagnosis of Alzheimer’s disease (AD). This test measures concentrations of phospho-tau 217 (p-Tau 217), a biomarker associated with […]